FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
Authors
Keywords
Epithelial ovarian cancer, Subtype, Prognosis, Chemoresistance, FOXM1, Cell line, Anticancer drug, Immunohistochemistry, Microarray
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-08
DOI
10.1186/s13046-017-0536-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Olaparib for the treatment of epithelial ovarian cancer
- (2016) Jennifer McLachlan et al. EXPERT OPINION ON PHARMACOTHERAPY
- Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues
- (2016) Eliana Bignotti et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
- (2016) Zhenfeng Zhang et al. Theranostics
- Complex Breakpoints and Template Switching Associated with Non-canonical Termination of Homologous Recombination in Mammalian Cells
- (2016) Andrea J. Hartlerode et al. PLoS Genetics
- In silico investigation of FOXM1 binding and novel inhibitors in epithelial ovarian cancer
- (2015) Yi Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3/DDP cells
- (2015) Z.M. Chen et al. GENETICS AND MOLECULAR RESEARCH
- TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin
- (2015) J. Erriquez et al. GYNECOLOGIC ONCOLOGY
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression
- (2015) Carter J Barger et al. Oncotarget
- Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression
- (2015) Liu Yang et al. Oncotarget
- Optimising the treatment of the partially platinum-sensitive relapsed ovarian cancer patient
- (2015) Nicoletta Colombo EJC SUPPLEMENTS
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
- (2014) Stefania Zona et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer
- (2014) Jia Li et al. BMB Reports
- Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
- (2014) Aki Miyasaka et al. BMC CANCER
- Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
- (2014) Alvaro Aytes et al. CANCER CELL
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
- (2014) Ning Wen et al. Journal of Translational Medicine
- CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma
- (2014) Huimin Shen et al. MEDICAL ONCOLOGY
- FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
- (2014) Jinhua Zhou et al. PLoS One
- Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
- (2014) Fung Zhao et al. PLoS One
- Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma
- (2013) Niloofar N. Nik et al. Annual Review of Pathology-Mechanisms of Disease
- New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
- (2013) D S P Tan et al. BRITISH JOURNAL OF CANCER
- Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells
- (2013) Sahiti Chukkapalli et al. EXPERIMENTAL CELL RESEARCH
- BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation
- (2013) Britta Stordal et al. Molecular Oncology
- Clinicopathological and functional significance of XRCC1 expression in ovarian cancer
- (2012) Tarek Abdel-Fatah et al. INTERNATIONAL JOURNAL OF CANCER
- Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
- (2012) Marianna Halasi et al. PLoS One
- Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells
- (2012) David W. Chan et al. PLoS One
- Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance
- (2012) Fung Zhao et al. Frontiers of Medicine
- Novel mechanism of reduced proliferation in ovarian clear cell carcinoma cells: Cytoplasmic sequestration of CDK2 by p27
- (2011) Hiroaki Itamochi et al. GYNECOLOGIC ONCOLOGY
- Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)
- (2011) Gordon John Sampson Rustin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Significance of Cell Cycle Regulatory Proteins as Malignant and Prognostic Biomarkers in Ovarian Epithelial Tumors
- (2011) Yoon Hee Lee et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
- (2011) Gabriel T. M. Lok et al. PLoS One
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma
- (2010) Ahmad Waseem et al. ORAL ONCOLOGY
- FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation
- (2009) Emilios Gemenetzidis et al. PLoS One
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
- (2008) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now